Atlas Trials

Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine

Clinical trial NCT00271479 · COMPLETED

Trial details

NCT number
NCT00271479
Sponsor
Epicentre
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Infections, MeningococcalMeningitis, Meningococcic
Start date
2004-06-01
Enrollment
720

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.